Karla Alfaro (El Salvador)
Basic Health International Medical Director
Presenter of 1 Presentation
TRAINING OF HEALTHCARE PROVIDERS FOR THE IMPLEMENTATION OF A NATIONAL CERVICAL CANCER PREVENTION PROGRAM IN EL SALVADOR (ID 1033)
Session Time
10:00 - 17:00
Session Type
Poster Viewing - 20-24 July
Session Name
Public Health / Epidemiology / Screening for HPV-related Disease: Implementation, Evaluation and Impact
Lecture Time
10:01 - 10:02
Introduction
Cervical cancer is the leading cause of cancer death for women in El Salvador. In 2012, human papillomavirus (HPV) testing was introduced to the country as part of Cervical Cancer Prevention in El Salvador (CAPE), a primary HPV-based screen-and-treat demonstration project. The success of CAPE led to its adoption by the Ministry of Health (MOH) and a subsequent national scale-up that is currently underway. Each step required rapid training of healthcare workers across the country. The CAPE training model can serve as a blueprint for other cervical cancer prevention programs in low and middle countries (LMICs).
Methods
The training model divided healthcare providers into three categories based on the MOH’s existing workforce (physicians, nurses, and community health promoters). The model included preparation of educational materials, training of healthcare workers, and monitoring of program implementation. Results from the regional expansion of CAPE and preliminary findings from the national scale-up are presented here.
Results
Training curricula were developed by Basic Health International (BHI) and the MOH with technical support provided by international agencies and experts. Specific materials were designed for each of the three categories of healthcare workers. Training took place over 3 months in the Paracentral region of the country. During this stage, CAPE trained 223 doctors, 360 nurses, and 610 health promoters. The regional expansion screened and treated 17,795 women over 24 months. The national scale-up has subsequently trained an additional 608 doctors, 920 nurses, and 1,534 health promoters in 3 months, while 30,000/100,000 projected women have been screened.
Conclusions
CAPE successfully trained public healthcare workers to implement a population- based cervical cancer screening program in a LMIC. Some of these workers are now capable of providing trainings to new members of the local workforce. The CAPE training model is a sustainable strategy to strengthen in-country capacity.
Hide
Moderator of 1 Session
Session Type
Public Health Oral Session
Session Time
11:35 - 13:15
[{"name":"LEVELS OF ANXIETY AND DISTRESS FOLLOWING RECEIPT OF POSITIVE SCREENING TESTS IN AUSTRALIA\u2019S HPV-BASED CERVICAL SCREENING PROGRAM: A CROSS-SECTIONAL SURVEY \u003Csmall\u003E(ID 384)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":384,"presentation":"LEVELS OF ANXIETY AND DISTRESS FOLLOWING RECEIPT OF POSITIVE SCREENING TESTS IN AUSTRALIA\u2019S HPV-BASED CERVICAL SCREENING PROGRAM: A CROSS-SECTIONAL SURVEY \u003Csmall\u003E(ID 384)\u003C\/small\u003E","session":"Oral Session 6: SCREENING III. Implementation, dissemination, and communication\u00a0","presenter":"Rachael H. Dodd (Australia)","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/ipvc20\/persons\/photos\/997.jpg"},"playlist":[{"name":"LEVELS OF ANXIETY AND DISTRESS FOLLOWING RECEIPT OF POSITIVE SCREENING TESTS IN AUSTRALIA\u2019S HPV-BASE","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/28\/Rachael Dodd - IPVC20 - PRESENTATION id 384.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/28\/Rachael Dodd - IPVC20 - PRESENTATION id 384.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/28\/21194003.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/28\/Rachael Dodd - IPVC20 - PRESENTATION id 384.vtt"}]},{"name":"EVOLVING AND VALIDATING NEW TOOL FOR TRAINING PARAMEDICAL STAFF IN CANCER AWARENESS AND CERVICAL CANCER SCREENING WITH VIA AND COLLECTION OF HPV AND CYTOLOGY SAMPLES \u003Csmall\u003E(ID 117)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":117,"presentation":"EVOLVING AND VALIDATING NEW TOOL FOR TRAINING PARAMEDICAL STAFF IN CANCER AWARENESS AND CERVICAL CANCER SCREENING WITH VIA AND COLLECTION OF HPV AND CYTOLOGY SAMPLES \u003Csmall\u003E(ID 117)\u003C\/small\u003E","session":"Oral Session 6: SCREENING III. Implementation, dissemination, and communication\u00a0","presenter":"Gauravi A. Mishra (India)","photo":""},"playlist":[{"name":"EVOLVING AND VALIDATING NEW TOOL FOR TRAINING PARAMEDICAL STAFF IN CANCER AWARENESS AND CERVICAL CAN","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/28\/GMT20200701-055823_Gauravi-Mi_1920x1080-1.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/28\/GMT20200701-055823_Gauravi-Mi_1920x1080-1.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/28\/2DAB3422.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/28\/GMT20200701-055823_Gauravi-Mi_1920x1080-1.vtt"}]},{"name":"AUSTRALIA\u2019S NEW CERVICAL SCREENING PROGRAM: FINDINGS FROM THE STAKEHOLDERS OPINIONS OF RENEWAL IMPLEMENTATION AND EXPERIENCES STUDY (STORIES) \u003Csmall\u003E(ID 708)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":708,"presentation":"AUSTRALIA\u2019S NEW CERVICAL SCREENING PROGRAM: FINDINGS FROM THE STAKEHOLDERS OPINIONS OF RENEWAL IMPLEMENTATION AND EXPERIENCES STUDY (STORIES) \u003Csmall\u003E(ID 708)\u003C\/small\u003E","session":"Oral Session 6: SCREENING III. Implementation, dissemination, and communication\u00a0","presenter":"Julia M. Brotherton (Australia)","photo":""},"playlist":[{"name":"AUSTRALIA S NEW CERVICAL SCREENING PROGRAM FINDINGS FROM THE STAKEHOLDERS OPINIONS OF RENEWAL IMPLEM","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/28\/Julia Brotherton - IPVC20 - 708 - AUSTRALIA S NEW CERVICAL SCREENING PROGRAM FINDINGS FROM THE STAKEHOLDERS OPINIONS OF RENEWAL IMPLEMENTATION AND EXPERIENCES STUDY (STORIES).mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/28\/Julia Brotherton - IPVC20 - 708 - AUSTRALIA S NEW CERVICAL SCREENING PROGRAM FINDINGS FROM THE STAKEHOLDERS OPINIONS OF RENEWAL IMPLEMENTATION AND EXPERIENCES STUDY (STORIES).mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/28\/4E2E0E02.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/28\/Julia Brotherton - IPVC20 - 708 - AUSTRALIA S NEW CERVICAL SCREENING PROGRAM FINDINGS FROM THE STAKEHOLDERS OPINIONS OF RENEWAL IMPLEMENTATION AND EXPERIENCES STUDY (STORIES).vtt"}]},{"name":"RISK STRATIFICATION IN CERVICAL CANCER SCREENING \u2013 VALIDATION AND GENERALIZATION OF A DATA-DRIVEN SCREENING HISTORY EVALUATION MODEL \u003Csmall\u003E(ID 818)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":818,"presentation":"RISK STRATIFICATION IN CERVICAL CANCER SCREENING \u2013 VALIDATION AND GENERALIZATION OF A DATA-DRIVEN SCREENING HISTORY EVALUATION MODEL \u003Csmall\u003E(ID 818)\u003C\/small\u003E","session":"Oral Session 6: SCREENING III. Implementation, dissemination, and communication\u00a0","presenter":"Karin Sundstr\u00f6m (Sweden)","photo":""},"playlist":[{"name":"RISK STRATIFICATION IN CERVICAL CANCER SCREENING \u2013 VALIDATION AND GENERALIZATION OF A DATA-DRIVEN SC","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/28\/GMT20200611-115216_Karin-Sund_1920x1080.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/28\/GMT20200611-115216_Karin-Sund_1920x1080.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/28\/6BB920D0.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/28\/GMT20200611-115216_Karin-Sund_1920x1080.vtt"}]},{"name":"META-ANALYSIS ON THE ACCURACY OF METHODS TO TRIAGE HRHPV-POSITIVE WOMEN \u003Csmall\u003E(ID 1252)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1252,"presentation":"META-ANALYSIS ON THE ACCURACY OF METHODS TO TRIAGE HRHPV-POSITIVE WOMEN \u003Csmall\u003E(ID 1252)\u003C\/small\u003E","session":"Oral Session 6: SCREENING III. Implementation, dissemination, and communication\u00a0","presenter":"Marc Arbyn (Belgium)","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/ipvc20\/persons\/photos\/2141.jpg"},"playlist":[{"name":"Marc Arbyn - IPVC20 - 1252 - THE ACCURACY OF METHODS TO TRIAGE HRHPV-POSITIVE WOMEN","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/28\/Marc Arbyn - IPVC20 - 1252 - THE ACCURACY OF METHODS TO TRIAGE HRHPV-POSITIVE WOMEN.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/28\/Marc Arbyn - IPVC20 - 1252 - THE ACCURACY OF METHODS TO TRIAGE HRHPV-POSITIVE WOMEN.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/28\/7BF6FDA.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/28\/Marc Arbyn - IPVC20 - 1252 - THE ACCURACY OF METHODS TO TRIAGE HRHPV-POSITIVE WOMEN.vtt"}]},{"name":"ESTIMATING THE EFFECTS OF AGE AT STARTING SCREENING AND SCREENING INTERVAL FROM ENGLISH CERVICAL CANCER RATES \u003Csmall\u003E(ID 1277)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1277,"presentation":"ESTIMATING THE EFFECTS OF AGE AT STARTING SCREENING AND SCREENING INTERVAL FROM ENGLISH CERVICAL CANCER RATES \u003Csmall\u003E(ID 1277)\u003C\/small\u003E","session":"Oral Session 6: SCREENING III. Implementation, dissemination, and communication\u00a0","presenter":"Julian Peto (United Kingdom)","photo":""},"playlist":[{"name":"ESTIMATING THE EFFECTS OF AGE AT STARTING SCREENING AND SCREENING INTERVAL FROM ENGLISH CERVICAL CAN","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/28\/Julian Peto IPVC20 1277 ESTIMATING THE EFFECTS OF AGE AT STARTING SCREENING AND SCREENING INTERVAL FROM ENGLISH CERVICAL CANCER RATES.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/28\/Julian Peto IPVC20 1277 ESTIMATING THE EFFECTS OF AGE AT STARTING SCREENING AND SCREENING INTERVAL FROM ENGLISH CERVICAL CANCER RATES.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/28\/1AEF74D7.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/28\/Julian Peto IPVC20 1277 ESTIMATING THE EFFECTS OF AGE AT STARTING SCREENING AND SCREENING INTERVAL FROM ENGLISH CERVICAL CANCER RATES.vtt"}]}]
{"type":2,"code":"6E32UU0u"}
[session]
[presentation]
[presenter]